Four years' monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai-Myanmar border

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Phompradit, Papichaya ^a   Muhamad, Poonuch ^a   Wisedpanichkij, Raewadee ^b   Chaijaroenkul, Wanna ^a   Na Bangchang, Kesara ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Artesunate; Gene polymorphisms; Mefloquine; pfatp6; pfcrt; pfmdr1; pfmrp1; Plasmodium falciparum

Indexed keywords

ARTESUNATE PLUS MEFLOQUINE; CHLOROQUINE; GENOMIC DNA; MOLECULAR MARKER; QUININE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CAMBODIA; DNA POLYMORPHISM; GENE AMPLIFICATION; GENE DOSAGE; GENE MUTATION; HUMAN; IC 50; IN VITRO STUDY; MALARIA FALCIPARUM; MULTIDRUG RESISTANCE; PARASITE CULTIVATION; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; REAL TIME POLYMERASE CHAIN REACTION; THAILAND;

ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; DRUG COMBINATIONS; DRUG RESISTANCE; MEFLOQUINE; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; QUININE; SEASONS; THAILAND; TIME FACTORS;

EID: 84892717188     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-23     Document Type: Article

References (46)

1. Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia. Verdrager J, J Trop Med Hyg 1986 89 277 289 3543384
2. Intercontinental spread of pyrimethamine-resistant malaria. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T, Science 2004 305 1124 10.1126/science.1098876 15326348
3. High prevalence of mefloquine-resistant falciparum malaria in eastern Thailand. Fontanet AL, Johnston DB, Walker AM, Rooney W, Thimasarn K, Sturchler D, Macdonald M, Hours M, Wirth DF, Bull World Health Organ 1993 71 377 383 8324857
4. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. Nosten F, Luxemburger C, ter Kuile FO, Woodrow C, Eh JP, Chongsuphajaisiddhi T, White NJ, J Infect Dis 1994 170 971 977 10.1093/infdis/170.4.971 7930743
5. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, Brockman A, McGready R, ter Kuile F, Looareesuwan S, White NJ, Lancet 2000 356 297 302 10.1016/S0140-6736(00)02505-8 11071185
6. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Noedl H, Se Y, Sriwichai S, Schaecher K, Teja-Isavadharm P, Smith B, Rutvisuttinunt W, Bethell D, Surasri S, Fukuda MM, Socheat D, Chan Thap L, Clin Infect Dis 2010 51 82 e89 10.1086/657120 21028985
7. Emerging artemisinin resistance in the border areas of Thailand. Na-Bangchang K, Karbwang J, Expert Rev Clin Pharmacol 2013 6 307 322 10.1586/ecp.13.17 23656342
8. Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria. Congpuong K, Bualombai P, Banmairuroi V, Na-Bangchang K, Malar J 2010 9 43 10.1186/1475-2875-9-43 20132537
9. Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border. Na-Bangchang K, Ruengweerayut R, Mahamad P, Ruengweerayut K, Chaijaroenkul W, Malar J 2010 9 273 10.1186/1475-2875-9-273 20929590
10. Transporters as mediators of drug resistance in Plasmodium falciparum. Sanchez C, Dave A, Stein W, Lanzer M, Int J Parasitol 2010 40 1109 1118 10.1016/j.ijpara.2010.04.001 20399785
11. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalon O, Lancet 2005 366 1960 1963 10.1016/S0140-6736(05)67787-2 16325698
12. Plasmodium falciparum multidrug resistance protein 1 and artemisinin-based combination therapy in Africa. Dahlstrom S, Ferreira PE, Veiga MI, Sedighi N, Wiklund L, Martensson A, Farnert A, Sisowath C, Osorio L, Darban H, Andersson B, Kaneko A, Conseil G, Björkman A, Gil JP, J Infect Dis 2009 200 1456 1464 10.1086/606009 19807279
13. Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione. Raj DK, Mu J, Jiang H, Kabat J, Singh S, Sullivan M, Fay MP, McCutchan TF, Su XZ, J Biol Chem 2009 284 7687 7696 10.1074/jbc.M806944200 19117944
14. Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance. Veiga MI, Ferreira PE, Jornhagen L, Malmberg M, Kone A, Schmidt BA, Petzold M, Bjorkman A, Nosten F, Gil JP, PLoS One 2011 6 20212 10.1371/journal.pone.0020212 21633513
15. Human malaria parasites in continuous culture. Trager W, Jensen JB, Science 1976 193 673 675 10.1126/science.781840 781840
16. Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy. Bennett TN, Paguio M, Gligorijevic B, Seudieu C, Kosar AD, Davidson E, Roepe PD, Antimicrob Agents Chemother 2004 48 1807 1810 10.1128/AAC.48.5.1807-1810.2004 15105139
17. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M, Antimicrob Agents Chemother 2004 48 1803 1806 10.1128/AAC.48.5. 1803-1806.2004 15105138
18. Molecular analysis of pfatp6 and pfmdr1 polymorphisms and their association with in vitro sensitivity in Plasmodium falciparum isolates from the Thai-Myanmar border. Phompradit P, Wisedpanichkij R, Muhamad P, Chaijaroenkul W, Na-Bangchang K, Acta Trop 2011 120 130 135 10.1016/j.actatropica.2011.07.003 21777558
19. PCR and strain identification in Plasmodium falciparum. Wooden J, Kyes S, Sibley CH, Parasitol Today 1993 9 303 305 10.1016/0169-4758(93)90131-X 15463789
20. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naude B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE, Mol Cell 2000 6 861 871 10.1016/S1097-2765(05)00077-8 11090624
21. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Duraisingh MT, Cowman AF, Acta Trop 2005 94 181 190 10.1016/j.actatropica.2005. 04.008 15876420
22. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC, Mol Biochem Parasitol 2000 108 13 23 10.1016/S0166-6851(00)00201-2 10802315
23. Plasmodium falciparum from para state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA-type PfATPase6. Ferreira ID, Martinelli A, Rodrigues LA, do Carmo EL, do Rosario VE, Povoa MM, Cravo P, Trop Med Int Health 2008 13 199 207 10.1111/j.1365-3156.2007.01991.x 18304266
24. Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76 T and pfmdr1 86Y. Holmgren G, Gil JP, Ferreira PM, Veiga MI, Obonyo CO, Bjorkman A, Infect Genet Evol 2006 6 309 314 10.1016/j.meegid.2005.09.001 16271310
25. Mutation analysis in pfmdr1 and pfmrp1 as potential candidate genes for artemisinin resistance in Plasmodium falciparum clinical isolates 4years after implementation of artemisinin combination therapy in Iran. Pirahmadi S, Zakeri S, Afsharpad M, Djadid ND, Infect Genet Evol 2013 14 327 334 23287027
26. Real-time quantitative PCR with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium falciparum. Ferreira I, do Rosário VE, Cravo P, Malar J 2006 5 1 10.1186/1475-2875-5- 1 16420686
27. In vitro sensitivity of Plasmodium falciparum to artesunate in Thailand. Wongsrichanalai C, Wimonwattrawatee T, Sookto P, Laoboonchai A, Heppner D, Kyle D, Wernsdorfer W, Bull World Health Organ 1999 77 392 398 10361756
28. In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003. Chaijaroenkul W, Bangchang KN, Mungthin M, Ward SA, Malar J 2005 4 37 10.1186/1475-2875-4-37 16060967
29. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate. Chaijaroenkul W, Wisedpanichkij R, Na-Bangchang K, Acta Trop 2010 113 190 194 10.1016/j.actatropica.2009.10.016 19879850
30. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp A, Nosten F, Yi P, Das D, Phyo A, Tarning J, Lwin K, Ariey F, Hanpithakpong W, Lee S, Ringwald P, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
31. Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
32. Drug-resistant malaria in Bangladesh: an in vitro assessment. Noedl H, Faiz MA, Yunus EB, Rahman MR, Hossain MA, Samad R, Miller RS, Pang LW, Wongsrichanalai C, Am J Trop Med Hyg 2003 68 140 142 12641401
33. Comparative study of the in vitro sensitivity of Plasmodium falciparum to artemisinin in two border areas of Thailand. Woitsch B, Wernsdorfer G, Prajakwong S, Rojanawatsirivet C, Kollaritsch H, Wernsdorfer WH, Wiener klinische Wochenschrift 2004 116 Suppl 4 35 40 15683041
34. Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity. Na-Bangchang K, Muhamad P, Ruaengweerayut R, Chaijaroenkul W, Karbwang J, Malar J 2013 12 263 10.1186/1475-2875-12-263 23898808
35. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Rogers WO, Sem R, Tero T, Chim P, Lim P, Muth S, Socheat D, Ariey F, Wongsrichanalai C, Malar J 2009 8 10 10.1186/1475-2875-8-10 19138388
36. In vitro susceptibility of Plasmodium falciparum isolates from Myanmar to antimalarial drugs. Wongsrichanalai C, Lin K, Pang L, Faiz M, Noedl H, Wimonwattrawatee T, Laoboonchai A, Kawamoto F, Am J Trop Med Hyg 2001 65 450 455 11716097
37. Drug sensitivity of Plasmodium falciparum along the Thai-Myanmar border using the new field-deployable HRP2 in vitro assay. Attlmayr B, Kollaritsch H, Wernsdorfer W, Miller R, Sirichaisinthop J, Noedl H, Wien Klin Wochenschr 2005 117 35 38
38. A molecular marker for chloroquine-resistant falciparum malaria. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152
39. Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007. Lim P, Wongsrichanalai C, Chim P, Khim N, Kim S, Chy S, Sem R, Nhem S, Yi P, Duong S, et al. Antimicrob Agents Chemother 2010 54 2135 2142 10.1128/AAC.01304-09 20194689
40. Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184 F mutation in Cambodia. Vinayak S, Alam MT, Sem R, Shah NK, Susanti AI, Lim P, Muth S, Maguire JD, Rogers WO, Fandeur T, Barnwell JW, Escalante AA, Wongsrichanalai C, Ariey F, Meshnick SR, Udhayakumar V, J Infect Dis 2010 201 1551 1560 10.1086/651949 20367478
41. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Sidhu AB, Valderramos SG, Fidock DA, Mol Microbiol 2005 57 913 926 10.1111/j.1365-2958.2005.04729.x 16091034
42. In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005. Legrand E, Volney B, Meynard JB, Mercereau-Puijalon O, Esterre P, Antimicrob Agents Chemother 2008 52 288 298 10.1128/AAC.00263-07 17954693
43. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Price RN, Cassar C, Brockman A, Duraisingh M, van Vugt M, White NJ, Nosten F, Krishna S, Antimicrob Agents Chemother 1999 43 2943 2949 10582887
44. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S, Lancet 2004 364 438 447 10.1016/S0140-6736(04)16767-6 15288742
45. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. Carrara VI, Zwang J, Ashley EA, Price RN, Stepniewska K, Barends M, Brockman A, Anderson T, McGready R, Phaiphun L, Proux S, van Vugt M, Hutagalung R, Lwin KM, Phyo AP, Preechapornkul P, Imwong M, Pukrittayakamee S, Singhasivanon P, White NJ, Nosten F, PLoS One 2009 4 4551 10.1371/journal.pone.0004551 19234601
46. Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy. Krishna S, Kremsner PG, Trends Parasitol 2013 29 313 317 10.1016/j.pt.2013.04.001 23623760